ALTERITY THERAPEUTICS-ADR (ATHE:NASDAQ)
$4.565 -0.1 (-2.1436%)
Analysed ALTERITY THERAPEUTICS-ADR (ATHE:NASDAQ) News Sources
Alterity Therapeutics Presents New Analysis of ATH434 Phase 2 Trial Data in Late Breaking Science Session of the American Academy of Neurology
22-04-2026
yahoo.com
Alterity Therapeutics Receives Positive FDA Feedback Following Second Type C Meeting on ATH434 Phase 3 Program in Multiple System Atrophy
27-04-2026
yahoo.com
Alterity Therapeutics Releases Appendix 4C – Q3 FY26 Quarterly Cash Flow Report & Corporate Update
30-04-2026
yahoo.com
Alterity Therapeutics to Deliver Presentations at Multiple Medical Conferences in May 2026
07-05-2026
yahoo.com
Alterity Therapeutics Announces Publication Demonstrating the Utility of Quantitative MRI as a Biomarker for Multiple System Atrophy
11-05-2026
yahoo.com
Alterity Therapeutics Data Presentations Support Advancement of ATH434 into Phase 3 in Multiple System Atrophy
19-05-2026
yahoo.com
Alterity Therapeutics Achieves Alignment with U.S. FDA on Pivotal Phase 3 Program for ATH434 in Multiple System Atrophy
09-06-2026
yahoo.com
Is Allarity Therapeutics, Inc. (ALLR) Outperforming Other Medical Stocks This Year?
19-06-2026
yahoo.com
Alterity Therapeutics Receives FDA End-of-Phase 2 Meeting Minutes Confirming Registrational Pathway for ATH434 in Multiple System Atrophy
07-07-2026
yahoo.com
Alterity Therapeutics to Participate in the Virtual BTIG Biotechnology Conference 2026
21-07-2026
yahoo.com
What is the current price of ALTERITY THERAPEUTICS-ADR (ATHE:NASDAQ)?
The current price of ALTERITY THERAPEUTICS-ADR (ATHE:NASDAQ) is $4.565.
ALTERITY THERAPEUTICS-ADR (ATHE:NASDAQ) absolute price change since previous trading day?
The absolute price change of ALTERITY THERAPEUTICS-ADR (ATHE:NASDAQ) since the previous trading day is $-0.1.
ALTERITY THERAPEUTICS-ADR (ATHE:NASDAQ) percentage price change since previous trading day?
The percentage price change of ALTERITY THERAPEUTICS-ADR (ATHE:NASDAQ) since the previous trading day is -2.1436%.
What is the most recent average sentiment score for ALTERITY THERAPEUTICS-ADR (ATHE:NASDAQ)?
The most recent average sentiment score for ALTERITY THERAPEUTICS-ADR (ATHE:NASDAQ) is 72 out of 100.
What is the most recent average sentiment for ALTERITY THERAPEUTICS-ADR (ATHE:NASDAQ)?
The most recent sentiment for ALTERITY THERAPEUTICS-ADR (ATHE:NASDAQ) is .
SEC-8K** Filing Available For ALTERITY THERAPEUTICS-ADR (ATHE:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.